Lamivudine monoprophylaxis for de novo HBV infection in HBsAg-negative recipients with HBcAb-positive liver grafts.
Vizzini
Giovanni
G
Istituto Mediterraneo Trapianti e Terapie ad Alta Specializzazione, Palermo, Italy. gvizzini@ismett.edu
Gruttadauria
Salvatore
S
Volpes
Riccardo
R
D'Antoni
Adele
A
Pietrosi
Giada
G
Filì
Daniela
D
Petridis
Ioannis
I
Pagano
Duilio
D
Tuzzolino
Fabio
F
Santonocito
M Maria
MM
Gridelli
Bruno
B
D000293:Adolescent; D000328:Adult; D000368:Aged; D000369:Aged, 80 and over; D002102:Cadaver; D002648:Child; D004279:DNA, Viral / Q000032:analysis; D005260:Female; D005500:Follow-Up Studies; D006085:Graft Survival / Q000187:drug effects*; D006509:Hepatitis B / Q000188:drug therapy* / Q000276:immunology / Q000821:virology; D006510:Hepatitis B Antibodies / Q000276:immunology*; D006512:Hepatitis B Core Antigens / Q000276:immunology*; D006514:Hepatitis B Surface Antigens / Q000276:immunology*; D006515:Hepatitis B virus / Q000235:genetics / Q000302:isolation & purification; D006801:Humans; D019259:Lamivudine / Q000627:therapeutic use*; D016031:Liver Transplantation / Q000276:immunology*; D008297:Male; D008875:Middle Aged; D012008:Recurrence; D018894:Reverse Transcriptase Inhibitors / Q000627:therapeutic use; D015996:Survival Rate; D014019:Tissue Donors; D016896:Treatment Outcome; D014779:Virus Replication / Q000187:drug effects; D055815:Young Adult
D004279:DNA, Viral; D006510:Hepatitis B Antibodies; D006512:Hepatitis B Core Antigens; D006514:Hepatitis B Surface Antigens; D018894:Reverse Transcriptase Inhibitors; D019259:Lamivudine